Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug ...

But 2024 has fueled increasing optimism among leading infectious disease experts after the results of two groundbreaking ...

Lenacapavir for Alzheimer’s, an orca attacking a shark, and a moon landing are set to mark key scientific and technological ...

Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...

The post appears to reference the drug lenacapavir, which reportedly can cost around $40,000 annually in the U.S. and is administered in twice-yearly doses. While the drug appears to be effective ...

Psychedelic industry faced setbacks, cannabis was almost rescheduled and overdose deaths dropped — but not for all ...

This year we saw more examples of the destructive effort to undermine abortion as a health service. But overreach into health practices was not limited to abortion care.

ATLANTA - Lenacapavir, a new injectable drug for HIV prevention, is being hailed by Emory University medical experts as a breakthrough in the fight against the virus. The drug offers a long-acting ...